All 51 Analysts Rate Broadcom a Buy as Stock Trails Target by 50%

Not one of 51 analysts rates Broadcom (NASDAQ:AVGO) a Sell or Strong Sell, and the consensus price target of $533.42 sits 49.6% above the $356.54 opening price on November 13, 2026. Shares are up only 0.6% year to date. The stock rose 18.5% in one week as Broadcom led S&P 500 gainers amid turmoil at Nvidia, according to MarketWatch. The question facing investors is whether that unanimity is itself a risk.

What are bulls paying for?

The earnings record supports the consensus. Broadcom has beaten EPS estimates for nine consecutive quarters. In fiscal Q3, it posted non-GAAP EPS of $3.32 against a $3.24 consensus. Revenue of $29.59 billion exceeded the $29.44 billion estimate. AI semiconductor revenue rose 221% to $16.70 billion, and Q4 guidance calls for $21.7 billion.

Valuation also favors the bulls. The stock trades at 18x forward earnings compared with 44x trailing. The fiscal 2027 EPS consensus of $19.4651, drawn from 48 analysts, is up from $19.3807 thirty days earlier, with two upward revisions and none downward.

On CNBC's Halftime Report on October 27, Stephanie Link said Broadcom guided 2027 revenue to $115 billion, rising to $230 billion by 2028. She said the Anthropic deal secured about $60 billion in 2027 revenues. Jim Cramer said on CNBC on September 15: "Broadcom's view, there will be no slowdown, is the one that is going to take hold of the narrative." On October 28, Cramer added: "I wouldn't shoot Broadcom."

What is the bear case no analyst is making?

The strongest objections come from outside the analyst ranks. On the Halftime Report on October 27, Jenny Harrington said: "I think there's a problem when the CEO of Broadcom needs to intervene in the funding of another company." The same day, Cramer asked on CNBC: "What happens when the next deal comes with companies that aren't as good as Broadcom or Anthropic?" On November 2, Joe Terranova described Marvell Technology's $115 billion all-stock purchase of Lumentum on the Halftime Report this way: "They're chasing Broadcom, in my opinion."

Management has flagged its own constraints:

• Land
• Power
• Substrates
• HBM memory

The AI outlook depends on six XPU customers. Beating estimates has also failed to protect the stock. Shares fell 12.59% the day after the fiscal Q2 report and 11.43% after fiscal Q4 2025. Both quarters beat.

Where does the money stand?

Ratings are unanimous, but positioning is divided. Institutions own 79.7% of shares. In the latest 13F filings from tracked filers, for the quarter ended September 30, 2026, the only filer, Renaissance Technologies, cut its stake to 734 shares. That is a quarter-end snapshot and does not show current holdings.

Near-term estimates have flattened. The fiscal Q4 EPS consensus of $3.8377 is below the $3.8609 of 90 days ago. The price holds above the 50-day moving average of $346.13 but below the 200-day average of $367.12. A beta of 1.51 points to above-market swings.

What is the verdict for investors?

The consensus appears right on fundamentals. Results keep beating estimates. AI revenue is still accelerating. The forward multiple is modest for this growth rate. The roughly 50% gap to the target reflects the market pricing in financing and supply risk while demand signals remain strong. Investors can weigh the analysts' thesis against the volatility that comes with it.

The test comes with the next report, expected around December 10, 2026. Three checks matter: whether revenue reaches the guided $34.8 billion, whether gross margin holds near the guided 73%, and whether management adds detail on how it supports financing for its AI customers.